In vitro growth inhibitory activity of Medicines for Malaria Venture pathogen box compounds against Leishmania aethiopica

被引：0
|
作者：
Markos Tadele
Solomon M. Abay
Peter Asaga
Eyasu Makonnen
Asrat Hailu
机构：
[1] Ethiopian Institute of Agricultural Research,Animal Health Research Program
[2] College of Health Sciences,Department of Pharmacology and Clinical Pharmacy
[3] Addis Ababa University,Institute of Human Virology
[4] University Freiburg Medical Centre,Center for Innovative Drug Development and Therapeutic Trials for Africa (CDT Africa)
[5] College of Health Sciences,Department of Microbiology, Immunology and Parasitology
[6] Addis Ababa University,undefined
[7] College of Health Sciences,undefined
[8] Addis Ababa University,undefined
来源：
BMC Pharmacology and Toxicology | / 22卷
关键词：
Cutaneous leishmaniasis; Pathogen box;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] In vitro growth inhibitory activity of Medicines for Malaria Venture pathogen box compounds against Leishmania aethiopica
    Tadele, Markos
    Abay, Solomon M.
    Asaga, Peter
    Makonnen, Eyasu
    Hailu, Asrat
    BMC PHARMACOLOGY & TOXICOLOGY, 2021, 22 (01):
  • [2] Leishmania donovani Growth Inhibitors from Pathogen Box Compounds of Medicine for Malaria Venture
    Tadele, Markos
    Abay, Solomon M.
    Makonnen, Eyasu
    Hailu, Asrat
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2020, 14 : 1307 - 1317
  • [3] Screening the Medicines for Malaria Venture Pathogen Box against piroplasm parasites
    Nugraha, Arifin Budiman
    Tuvshintulga, Bumduuren
    Guswanto, Azirwan
    Tayebwa, Dickson Stuart
    Rizk, Mohamed Abdo
    Gantuya, Sambuu
    Batiha, Gaber El-Saber
    Beshbishy, Amany Magdy
    Sivakumar, Thillaiampalam
    Yokoyama, Naoaki
    Igarashi, Ikuo
    INTERNATIONAL JOURNAL FOR PARASITOLOGY-DRUGS AND DRUG RESISTANCE, 2019, 10 : 84 - 90
  • [4] Antileishmanial Activity of Compounds Derived from the Medicines for Malaria Venture Open Access Box against Intracellular Leishmania major Amastigotes
    Khraiwesh, Mozna
    Leed, Susan
    Roncal, Norma
    Johnson, Jacob
    Sciotti, Richard
    Smith, Philip
    Read, Lisa
    Paris, Robert
    Hudson, Thomas
    Hickman, Mark
    Grogl, Max
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2016, 94 (02): : 340 - 347
  • [5] Repositionable Compounds with Antifungal Activity against Multidrug Resistant Candida auris Identified in the Medicines for Malaria Venture's Pathogen Box
    Wall, Gina
    Herrera, Natalia
    Lopez-Ribot, Jose L.
    JOURNAL OF FUNGI, 2019, 5 (04)
  • [6] An Antiparasitic Compound from the Medicines for Malaria Venture Pathogen Box Promotes Leishmania Tubulin Polymerization
    Ullah, Imran
    Gahalawat, Suraksha
    Booshehri, Laela M.
    Niederstrasser, Hanspeter
    Majumdar, Shreoshi
    Leija, Christopher
    Bradford, James M.
    Hu, Bin
    Ready, Joseph M.
    Wetzel, Dawn M.
    ACS INFECTIOUS DISEASES, 2020, 6 (08): : 2057 - 2072
  • [7] Antimicrobial effects of Medicines for Malaria Venture Pathogen Box compounds on strains of Neisseria gonorrhoeae
    Mensah, Eric
    Fourie, P. Bernard
    Peters, Remco P. H.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2023, 67 (11)
  • [8] In Vitro Screening of the Open-Source Medicines for Malaria Venture Malaria and Pathogen Boxes To Discover Novel Compounds with Activity against Balamuthia mandrillaris
    Rice, Christopher A.
    Fernando Lares-Jimenez, Luis
    Lares-Villa, Fernando
    Kyle, Dennis E.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2020, 64 (05)
  • [9] Screening the Medicines for Malaria Venture Pathogen Box for invasion and egress inhibitors of the blood stage of Plasmodium falciparum reveals several inhibitory compounds
    Dans, Madeline G.
    Weiss, Greta E.
    Wilson, Danny W.
    Sleebs, Brad E.
    Crabb, Brendan S.
    de Koning-Ward, Tania F.
    Gilson, Paul R.
    INTERNATIONAL JOURNAL FOR PARASITOLOGY, 2020, 50 (03) : 235 - 252
  • [10] Early Antischistosomal Leads Identified from in Vitro and in Vivo Screening of the Medicines for Malaria Venture Pathogen Box
    Pasche, Valerian
    Laleu, Benoit
    Keiser, Jennifer
    ACS INFECTIOUS DISEASES, 2019, 5 (01): : 102 - 110
12345